Dillione Janet

SEC Form 4 insider trading activity

Dillione Janet has filed 7 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Sep 19, 2026.

On the most recent filing, Dillione Janet is listed as Director at CorMedix Inc. Inside the rolling window, Dillione Janet reported no open-market purchases and 5 open-market sales totaling $1.5M in CRMD. The largest disclosed transaction in the window is a sale of 46,657 CRMD shares on Dec 2, 2025, worth $467K.

Companies traded

Other insiders at CRMD

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.5M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
CRMDSale$69KJan 22SEC ↗
CRMDSale$408KDec 11SEC ↗
CRMDSale$467KDec 4SEC ↗
CRMDSale$262KNov 26SEC ↗
CRMDSale$343KNov 18SEC ↗
Showing 1–5 of 5
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Dillione Janet made?

Dillione Janet has filed 7 SEC Form 4 filings (16 transaction rows) across 1 company since 2025.

Which companies does Dillione Janet trade?

Dillione Janet has filed SEC Form 4 disclosures for 1 company, including CRMD.

When was Dillione Janet's most recent SEC Form 4 filing?

Dillione Janet's most recent SEC Form 4 filing on Tracefour is dated Sep 19, 2026.

What is Dillione Janet's total buy and sell value in the current window?

Inside the rolling retention window, Dillione Janet bought $0 and sold $1.5M based on SEC Form 4 filings.

What was Dillione Janet's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 46,657 CRMD shares on 2025-12-02, worth $467K, per SEC Form 4 filings.